GRTS
Gritstone Oncology Inc
Price:  
0.03 
USD
Volume:  
61,017,984.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GRTS WACC - Weighted Average Cost of Capital

The WACC of Gritstone Oncology Inc (GRTS) is 6.9%.

The Cost of Equity of Gritstone Oncology Inc (GRTS) is 31.00%.
The Cost of Debt of Gritstone Oncology Inc (GRTS) is 7.00%.

Range Selected
Cost of equity 25.60% - 36.40% 31.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.5% - 7.2% 6.9%
WACC

GRTS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 4.73 5.62
Additional risk adjustments 0.0% 0.5%
Cost of equity 25.60% 36.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 13.89 13.89
Cost of debt 7.00% 7.00%
After-tax WACC 6.5% 7.2%
Selected WACC 6.9%